Skip to content

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

DermScan - Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03818620
Acronym
DermScan
Enrollment
3000
Registered
2019-01-28
Start date
2017-06-07
Completion date
2025-04-30
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Cancer, Skin Diseases

Brief summary

This is a multicenter prospective observational clinical investigation with a medical device. The purpose of this study is to develop and validate of a new type of digital dermatoscope with automatic decision support algorithms. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Interventions

DEVICEBarco digital dermatoscope device images

Images of skin lesion taken with the Barco dermatoscope by site team member

DEVICEReference standard dermatoscope device images

Images of skin lesion taken with a standard dermatoscope device (as part of standard care)

Sponsors

Barco NV
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient has a lesion that is accessible to the Barco Digital Dermatoscope * Patient gives informed consent * Men or women of any ethnic group aged ≥ 18 years

Exclusion criteria

* Men or women of any ethnic group aged \< 18 years * Patients not willing or able to read, understand and sign the study-specific informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Development of anonymized database with over 3000 (potential) skin cancer cases for use in AI3.5 yearsDatabase of multispectral images of potential skin cancer lesions acquired with the Barco device together with clinical information (e.g. age, gender, history of skin cancer, histopathology diagnosis) and matched standard images using medical photography

Secondary

MeasureTime frameDescription
Comparison of new device to standard dermoscopy2 yearsCompare clinical performance and workflow efficiency of the Barco device to current standard of care (standard dermoscopy)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026